Evidence map›Paper›PMID 26245656›Full record

ArticleWorld journal of surgical oncology2015

Immunohistochemical expression of 8-oxo-7,8-dihydro-2'-deoxyguanosine in cytoplasm of tumour and adjacent normal mucosa cells in patients with colorectal cancer.

Petar Matosevic, Tajana Klepac-Pulanic, Emil Kinda, Goran Augustin, Iva Brcic, Jasminka Jakic-Razumovic

Abstract readComparative Study
In one paragraph

Article in World journal of surgical oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Analysis of blood markers for early colorectal cancer diagnosis.Journal of gastrointestinal oncology · 2022
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Petar MatosevicDepartment of Surgery, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. petar.matosevic@gmail.com.
Tajana Klepac-PulanicGynecology Department, Community Health Center Zagreb East, Vidriceva 38, 10000, Zagreb, Croatia. tklepacpulanic@gmail.com.
Emil KindaDepartment of Surgery, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. emil.kinda@gmail.com.
Goran AugustinDepartment of Surgery, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. augustin.goran@gmail.com.
Iva BrcicDepartment of Pathology, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. ibrcic@kbc-zagreb.hr.
Jasminka Jakic-RazumovicDepartment of Pathology, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. jasminkaster@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this research was to study the levels of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG) in tumour tissue samples of colorectal carcinoma based upon immunohistochemical detection and compare those results with patients' outcome.

methodsTumour blocks of patients surgically treated for colorectal cancer were evaluated by 8-oxodG immunohistochemical staining. The expression was analysed in 500 tumour cells. The percentage of positive cells, as well as staining intensity, was recorded, and Allred score was calculated. For each patient, data of age, gender, tumour size and location, margin status, histologic grade, tumour stage, lymph node status, vascular invasion, overall survival, and therapy protocols were collected. Tumour grade was divided into two groups as low and high grade.

resultsIn this study, 146 consecutive patients with primary colorectal carcinoma were included. All data were available for 138 patients, and they were included in this research. There were 83 male and 55 female patients; the median age was 64 years (range 35-87 years). The results showed shorter 5- and 10-year survival in patients with 8-oxodG positive tumour cells (5-year survival, n=138, Mantel-Cox, chi-square 4.116, degree of freedom (df)=1, p<0.05; 10-year survival, n=134, Mantel-Cox, chi-square 4.374, df=1, p<0.05). The results showed a positive correlation between Allred score and high tumour grade (two-tailed Spearman's ρ 0.184; p<0.05), as well as with non-polypoid tumour growth (two-tailed Spearman's ρ 0.198; p<0.05). There was no significant difference of 8-oxodG expression related to age, sex, blood group, size and tumour site, distance from the edge of the resected tumour margin, lymph nodes involvement, and vascular invasion.

conclusionsIn this study, the positive correlation between 8-oxodG presence in the tumour cells, worse clinical outcome, higher tumour grade, and flat morphology was found.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAdultAgedAged, 80 and overBiomarkers, TumorCase-Control StudiesColorectal NeoplasmsCytoplasmDeoxyguanosineFemaleFollow-Up StudiesHumansImmunoenzyme TechniquesMaleMiddle AgedMucous Membrane8-Hydroxy-2'-DeoxyguanosineBiomarkers, TumorDeoxyguanosine

Identifiers

PMID26245656
PMCPMC4527254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.